Peripheral vasculature in essential hypertension

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue 8, 1996, Pages s6-s10

  Mulvany, Michael J ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Determinants of blood pressure; Hypertension; Resistance vessels; Therapy; Vascular reserve; Vascular structure

Indexed keywords

ATENOLOL; PERINDOPRIL;

BLOOD PRESSURE; CONFERENCE PAPER; ESSENTIAL HYPERTENSION; HISTOLOGY; HUMAN; IN VITRO STUDY; VASCULAR RESISTANCE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; BLOOD VESSELS; HUMANS; HYPERTENSION; INDOLES; PERINDOPRIL; VASCULAR RESISTANCE;

EID: 0029862357     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1996.tb03034.x     Document Type: Article

References (37)

1. Johnson G. On certain points in the anatomy of Bright's disease of the kidney. Trans. R. Med. Chir. Soc. 1868; 51: 57-8.
2. Folkow B. Structural, myogenic, humoral and nervous factors controlling peripheral resistance. In: Harrington M (ed.). Hypotensive Drugs. Pergamon, London. 1956; 163-74.
3. Doyle AE, Black H. Reactivity to pressor agents in hypertension. Circ. Res. 1955; 12: 974-80.
4. Folkow B, Grimby G, Thulesius O. Adaptive structural changes of the vascular walls in hypertension and their relation to the control of the peripheral resistance. Acta Physiol. Scand. 1958; 44:255-72.
5. Egan BM, Schork N, Panis R, Hinderliter A. Vascular structure enhances regional resistance responses in mild essential hypertension. J. Hypertens. 1988; 6: 41-8.
6. Folkow B. Physiological aspects of primary hypertension. Physiol. Rev. 1982; 62: 347-504.
7. Mulvany MJ, Aalkjaer C. Structure and function of small arteries. Physiol. Rev. 1990; 70: 921-61.
8. Lever AF. Slow pressor mechanisms in hypertension: A role for hypertrophy of resistance vessels? J. Hypertens. 1986; 4: 515-24.
9. Strauer BE. Significance of coronary circulation in hypertensive heart disease for development and prevention of heart failure. Am. J. Cardiol. 1990; 65: G34-4I.
10. Mulvany MJ. Resistance vessel growth and remodelling: Cause or consequence in cardiovascular disease. J. Hum. Hypertens. 1995; 9: 479-85.
11. Furuyama M. Histometrical investigations of arteries in reference to arterial hypertension. TohokuJ. Exp. Med. 1962; 76: 388-414.
12. Su wa N, Takahashi T. Morphological and Morphometric Analysis of Circulation in Hypertension and Ischaemic Kidney. Urban & Schwarzenberg, Munich. 1971.
13. Aalkjaer C, Heagerty AM, Petersen KK, Swales JD, Mulvany MJ. Evidence for increased media thickness, increased neuronal aminé uptake, and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ. Res. 1987; 61: 181-6.
14. Izzard AS, Cragoe EJ, Heagerty AM. Intracellular pH in human resistance arteries in essential hypertension. Hypertension 1991; 17: 780-6.
15. Korsgaard N, Heagerty AM, Aalkjaer C, Bund SJ, Mulvany MJ. Histology of subcutaneous small arteries from patients with essential hypertension. Hypertension 1993; 22: 523-6.
16. Schiffrin EL, Deng LY, Larochelle P. Blunted effects of endothelin upon small subcutaneous resistance arteries of mild essential hypertensive patients. J. Hypertens. 1992; 10: 437-44.
17. Thybo NK, Stephens N, Cooper A, Aalkjaer C, Heagerty AM, Mulvany MJ. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995; 25: 474-81.
18. Short D. The vascular fault in chronic hypertension with particular reference to the role of medial hypertrophy. Lancet 1966; 1: 1302-4.
19. Laurent S, Girerd X, Mourad JJ et al. Elastic modulus of the radial artery wall material is not increased in patients with essential hypertension. Arterioscler. Thromb. 1994; 14: 1223-31.
20. Baumbach GL, Heistad DD. Remodeling of cerebral arterioles in chronic hypertension. Hypertension 1989; 13: 968-72.
21. Baumbach GL, Heistad DD. Adaptive changes in cerebral blood vessels during chronic hypertension. J. Hypertens. 1991; 9:987-91.
22. Heagerty AM, Aalkjaer C, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension: Dual processes of remodelling and growth. Hypertension 1993; 21: 391-7.
23. Campbell JH, Tachas G, Black MJ, Cockerill G, Campbell GR. Molecular biology of vascular hypertrophy. Basic Res. Cardiol. 1991;86(Suppl. I): 3-11.
24. Stouffer GA, Owens GK. Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-beta. Circ. Res. 1992; 70: 820-8.
25. Dubey RK, Roy A, Overbeck HW. Culture of renal arteriolar smooth muscle cells. Mitogenic responses to angiotensin II. Circ. Res. 1992;71:I143-52.
26. Griffin SA, Brown WC, Macpherson F et al. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 1991; 17: 626-35.
27. Schiffrin EL, Deng LY, Larochelle P. Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 1994; 23: 83-91.
28. Pickering GW. The role of the kidney in acute and chronic hypertension following renal artery constriction in the rabbit. Clin. Sci. 1945; 5: 229-47.
29. Brown AJ, Casals-Stenzel J, Gofford S, Lever AF, Morton JJ. Comparison of fast and slow presser effects of angiotensin II in the conscious rat. Am. J. Physiol. 1981; 241: H38I-8.
30. Korsgaard N, Mulvany MJ. Cellular hypertrophy in mesenteric resistance vessels from renal hypertensive rats. Hypertension 1988; 12: 162-7.
31. Muirhead EE, Pitcock JA, Nasjletti A, Brown P, Brooks B. The antihypertensive function of the kidney. Hypertension 1985; 7 (Suppl. 1): 1127-35.
32. Thybo NK, Korsgaard N, Eriksen S, Christenscn KL, Mulvany MJ. Dose-dependent effects of perindopril on blood pressure and on small artery structure. Hypertension 1994; 23: 659-66.
33. Korner PI, Bobik A, Jennings GL, Angus JA, Anderson WP. Significance of cardiovascular hypertrophy in the development and maintenance of hypertension. J. Cardiovasc. Pharmacol. 1991; 17 (Suppl. 2): S25-32.
34. Julius S. The blood pressure seeking properties of the central nervous system. J. Hypenens. 1988; 6: 177-85.
35. Bund SJ, West KP, Heagerty AM. Effects of protection on resistance artery morphology and reactivity in spontaneously hypertensive and Wistar-Kyoto rats. Circ. Res. 1991; 68: 1230-40.
36. Christensen KL, Jespersen LT, Mulvany MJ. Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to resistance vessel structure. J. Hypertens. 1989; 7: 83-90.
37. Korner PI, Angus JA. Structural determinants of vascular resistance properties in hypertension. Haemodynamic and model analysis.J. Vase. Res. 1992;29: 293-312.